CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Gut

• Publication date

  2010-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/gut.2009.189720PMID 20442202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tracheoesophageal fistula

  2010cited by this paper
• Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment.

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

  2009cited by this paper
• CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy

  2009cited by this paper
• SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation.

  2008cited by this paper
• The multiple roles of CUX1: insights from mouse models and cell-based assays.

  2008cited by this paper
• Endoscopic management of recurrent tracheoesophageal fistula.

  2008cited by this paper
• Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.

  2008cited by this paper
• The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.

  2008cited by this paper
• Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.

  2008cited by this paper
• Synthetic Serine Protease Inhibitor, Gabexate Mesilate, Prevents Nuclear Factor-κB Activation and Increases TNF-α-Mediated Apoptosis in Human Pancreatic Cancer Cells

  2007cited by this paper
• Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-kappaB activation and increases TNF-alpha-mediated apoptosis in human pancreatic cancer cells.

  2007cited by this paper
• Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells*

  2007cited by this paper
• Treatment of tracheoesophageal fistula in a child by using an endoscopic suturing device.

  2007cited by this paper
• WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer.

  2007cited by this paper
• CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation

  2007cited by this paper
• CUTL1 Is Phosphorylated by Protein Kinase A, Modulating Its Effects on Cell Proliferation and Motility*

  2006cited by this paper
• A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.

  2006cited by this paper
• Evidence-based diagnosis and staging of pancreatic cancer.

  2006cited by this paper
• Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.

  2006cited by this paper
• CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.

  2005cited by this paper
• CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness

  2005cited by this paper
• Hepatomegaly in transgenic mice expressing the homeobox gene Cux‐1

  2005cited by this paper
• Mechanisms of Disease: PI3K/AKT Signaling in Gastrointestinal Cancers

  2005cited by this paper
• Pharmacogenomic Identification of Targets for Adjuvant Therapy with the Topoisomerase Poison Camptothecin

  2004cited by this paper
• Prognostic Significance of Activated Akt Expression in Pancreatic Ductal Adenocarcinoma

  2004cited by this paper
• Closure of an iatrogenic tracheo-esophageal fistula with bronchoscopic gluing in a mechanically ventilated adult patient.

  2004cited by this paper
• Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer

  2003cited by this paper
• CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter.

  2003cited by this paper
• Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

  2003cited by this paper
• Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

  2003cited by this paper
• CDP/Cux Stimulates Transcription from the DNA Polymerase α Gene Promoter

  2003cited by this paper
• Transgenic overexpression of the oncofetal RNA binding protein KOC leads to remodeling of the exocrine pancreas.

  2003cited by this paper
• Genetic Ablation of the CDP/Cux Protein C Terminus Results in Hair Cycle Defects and Reduced Male Fertility

  2002cited by this paper
• Stents for esophageal disease

  2002cited by this paper
• Characterization of a tissue-specific CDP/Cux isoform, p75, activated in breast tumor cells.

  2002cited by this paper
• The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle.

  2001cited by this paper
• Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice.

  2001cited by this paper
• Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development.

  2001cited by this paper
• Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes.

  1999cited by this paper
• A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens.

  1998cited by this paper
• The mammalian Cut homeodomain protein functions as a cell‐cycle‐dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase

  1998cited by this paper
• Cell cycle‐dependent modifications in activities of pRb‐related tumor suppressors and proliferation‐specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells

  1997cited by this paper
• Conserved cut repeats in the human cut homeodomain protein function as DNA binding domains.

  1994cited by this paper
• A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

  1991cited by this paper

• Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics

  2025influential citation
• Targeted melanoma therapy: High-efficiency siRNA delivery with R8-PEI dissolvable microneedles.

  2025cites this paper
• miR-29a-3p compositely regulates the COL6A6/PTEN-PI3K/Akt/CUX1 feedback loop to participate in the proliferation and invasion of pituitary adenomas

  2025influential citation
• ATM inhibitors in cancer radiotherapy: Mechanisms, clinical development, and future directions.

  2025cites this paper
• Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies.

  2024cites this paper
• The homeobox transcription factor Cux1 coordinates postnatal epithelial developmental timing but is dispensable for lung organogenesis and regeneration

  2024cites this paper
• Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma

  2023cites this paper
• CUT homeobox genes: transcriptional regulation of neuronal specification and beyond

  2023cites this paper
• Cut homeodomain transcription factor is a novel regulator of growth and morphogenesis of cortex glia niche around neural cells.

  2023cites this paper
• Mapping cardiac remodeling in chronic kidney disease

  2023cites this paper
• Genomic studies controvert the existence of the CUX1 p75 isoform

  2022cites this paper
• Base excision repair accessory factors in senescence avoidance and resistance to treatments

  2022cites this paper
• Aberrant transcription factors in the cancers of the pancreas.

  2022cites this paper
• N6-Methyladenosine Methylome Profiling of Muscle and Adipose Tissues Reveals Methylase–mRNA Metabolic Regulatory Networks in Fat Deposition of Rex Rabbits

  2022cites this paper
• CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation

  2021cites this paper
• Regulatory variants active in iPSC-derived pancreatic progenitor cells are associated with Type 2 Diabetes in adults

  2021cites this paper
• In silico discovery of small molecules for efficient stem cell differentiation into definitive endoderm

  2021cites this paper
• MicroRNA-122 overexpression promotes apoptosis and tumor suppressor gene expression induced by microcystin-leucine arginine in mouse liver

  2021cites this paper
• CUT Domain Proteins in DNA Repair and Cancer

  2021cites this paper
• Nonviral siRNA delivery systems for pancreatic cancer therapy

  2021cites this paper
• TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway

  2021cites this paper
• ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development

  2021cites this paper
• Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia

  2021cites this paper
• CUT Domains Stimulate Pol β Enzymatic Activities to Accelerate Completion of Base Excision Repair.

  2021cites this paper
• The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer

  2020cites this paper
• Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs.

  2020cites this paper
• PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition

  2020cites this paper
• Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

  2020cites this paper
• The involvement of noncanonical Wnt signaling in cancers.

  2020cites this paper
• Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response

  2020cites this paper
• Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages

  2020cites this paper
• CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors

  2020cites this paper
• CUX1, A Controversial Player in Tumor Development

  2020cites this paper
• Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma

  2020cites this paper
• Distinct clinical and biological implications of CUX1 in myeloid neoplasms.

  2019influential citation
• The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism.

  2019cites this paper
• 5‐Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT‐Dependent and Independent Manners

  2019cites this paper
• Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis

  2019cites this paper
• Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells

  2019cites this paper
• Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins

  2018cites this paper
• Matrine reversed multidrug resistance of breast cancer MCF‐7/ADR cells through PI3K/AKT signaling pathway

  2018cites this paper
• CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide

  2018cites this paper
• BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells

  2018cites this paper
• CUX2 functions as an oncogene in papillary thyroid cancer

  2018cites this paper
• Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential

  2018cites this paper
• Identification of differentially expressed genes and biological pathways in bladder cancer

  2018cites this paper
• The DNA repair function of CUX1 contributes to radioresistance

  2017cites this paper
• MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

  2017cites this paper
• Correction to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

  2017cites this paper
• Dermokine contributes to epithelial–mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer

  2017cites this paper
• Global view of a drug-sensitivity gene network

  2017cites this paper
• Targeting apurinic/apyrimidinic endonuclease 1 and 8-oxoguanine DNA glycosylase as a therapeutic strategy in acute myeloid leukaemia

  2017cites this paper
• Strategies to Target Pancreatic Cancer

  2016cites this paper
• Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells

  2016cites this paper
• miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer

  2016cites this paper
• Human Umbilical Cord Blood Cells Induce Neuroprotective Change in Gene Expression Profile in Neurons after Ischemia through Activation of Akt Pathway

  2015cites this paper
• Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

  2015cites this paper
• CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers

  2014cites this paper
• CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.

  2014influential citation
• Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers

  2014cites this paper
• The Transcription Factor Cux1 in Cerebellar Granule Cell Development and Medulloblastoma Pathogenesis

  2014cites this paper
• Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method

  2014cites this paper
• Polycation-based nanoparticles for RNAi-mediated cancer treatment.

  2014cites this paper
• Current and future intratumoral targeted treatment for pancreatic cancer.

  2014cites this paper
• Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.

  2014cites this paper
• Local siRNA delivery by non-viral vectors

  2014cites this paper
• RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage

  2014cites this paper
• Multifunctional Role of ATM/Tel1 Kinase in Genome Stability: From the DNA Damage Response to Telomere Maintenance

  2014cites this paper
• ATM signalling and cancer

  2014cites this paper
• Cutl1: a potential target for cancer therapy.

  2013cites this paper
• Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array

  2013cites this paper
• Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?

  2013cites this paper
• CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling

  2013cites this paper
• Polymer-based delivery of RNA-based therapeutics in ovarian cancer.

  2013cites this paper
• Supplementary information Inactivating CUX1 mutations promote tumorigenesis

  2013cites this paper
• The effect of growth restriction and postnatal fluctuating oxygen on the developing brain

  2013cites this paper
• WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.

  2013cites this paper
• CUX1 (cut-like homeobox 1)

  2012cites this paper
• Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer.

  2012cites this paper
• CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases.

  2012cites this paper
• Antagonistic Regulation of Apoptosis and Differentiation by the Cut Transcription Factor Represents a Tumor-Suppressing Mechanism in Drosophila

  2012cites this paper
• Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy.

  2012cites this paper
• Pancreatic Ductal Adenocarcinoma

  2012cites this paper
• Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.

  2012cites this paper
• Alterations in microRNA expression linked to microcystin-LR-induced tumorigenicity in human WRL-68 Cells.

  2012cites this paper
• Gene signatures of genomic instability as prognostic tools for breast cancer.

  2011cites this paper
• A Simple and Cost-Effective Method to Transfect Small Interfering RNAs Into Pancreatic Cancer Cell Lines Using Polyethylenimine

  2011cites this paper
• Molecular biology of pancreatic cancer.

  2011cites this paper
• Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.

  2011cites this paper
• Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives

  2011cites this paper
• The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)

  2010cites this paper
• Screening Technologies for Target Identification in Pancreatic Cancer

  2010cites this paper
• Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.

  2010cites this paper
• P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells

  2010cites this paper
• CUX1 mediates tumour cell survival: implications for future therapies?

  2010cites this paper
• Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

  2010cites this paper
• SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis.

  2010cites this paper
• SKP 2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis

  year unknowncites this paper